Aprameya Engineering
- Market cap
- ₹ 171 Cr.
- P/E
- 35.8x
- P/B
- 2.39x
- 52-week range
- 75 – 360
- ROE
- 8%
- ROCE
- 12.6%
- Dividend yield
- 0%
- Debt / equity
- 0.1
- Sector
- Healthcare Equipment & Supplies
- Industry
- Medical Equipment & Supplies
- Listed on
- NSE SME
About
Aprameya Engineering Limited is an India-based company. The Company specializes in setting up and maintaining intensive care units (ICUs), neonatal intensive care units (NICUs), pediatric intensive care units (PICUs), operation theatres, dialysis centers, and prefabricated wards on a turnkey basis for private and government hospitals. It also supplies medical and diagnostic equipment to hospitals and medical practitioners. Its segments include trading medical support equipment (trading sales) and supplies for infra projects for the health care sector (Turnkey project supplies). Its trading sales segment provides tailored solutions for cardiology, neurology, anesthesiology, nephrology, biochemistry, homecare, surgery, radiology. It also provides equipment sales, installation, training, and commissioning (SITC) for healthcare providers. Its Turnkey project supplies segment provides architectural design, interior design, structural design, mechanical, electrical, and plumbing design.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Medical Equipment & Supplies: 25 companies →Aprameya Engineering against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)35.8 against a typical 28.7: pricier than most peers (1st = cheapest).16th of 25
- Share price, 3 months−34.8% against a typical −7.9%.23rd of 23
- Size₹ 171.2 Cr. market value against a typical ₹ 238.1 Cr. (1st = largest).13th of 24
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 14 Nov 2026Upcoming | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2026 and other business matters |
| 28 May 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2026 and other business matters |
| 10 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 8 May 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2025 and other business matters |
| 11 Nov 2024 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2024 and other business matters |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 9 | 126 | 42 | 13 |
| Expenses | 11 | 101 | 31 | 13 |
| Operating Profit | −1 | 26 | 11 | −1 |
| OPM % | −14.9% | 20.4% | 26.2% | −4.8% |
| Other Income | 0 | 0 | 0 | 0 |
| Interest | 1 | 2 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 0 |
| Profit before tax | −2 | 24 | 9 | −2 |
| Tax % | −24.8% | 25.7% | 26% | −12.2% |
| Net Profit | −2 | 18 | 7 | −2 |
| EPS in Rs | −0.91 | 9.37 | 3.55 | −0.9 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 16%
- 3 Years
- −11%
- TTM
- −60%
- 10 Years
- —
- 5 Years
- 42%
- 3 Years
- −3%
- TTM
- −69%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- —
- 5 Years
- 24%
- 3 Years
- 19%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Aprameya Engineering | ₹ 96.00 | ₹ 171 Cr. | 35.8x | 2.4x | 8% | — |
| DLF | ₹ 653.55 | ₹ 1,61,774 Cr. | 39x | 3.6x | 10% | 32% |
| Lodha Developers | ₹ 963.00 | ₹ 1,01,441 Cr. | 33.7x | 5.1x | 15.8% | 20.6% |
| Indus Towers | ₹ 380.00 | ₹ 1,00,250 Cr. | 14.9x | 2.7x | 19.8% | 22% |
| Oberoi Realty | ₹ 1,587.20 | ₹ 57,846 Cr. | 27.3x | 3.8x | — | 41.6% |
| Godrej Properties | ₹ 1,497.90 | ₹ 45,121 Cr. | 166x | 3.3x | 10.2% | 35.9% |
Management
- Saurabh Kishorbhai Bhatt
- Executive Chairman of the Board, Joint Managing Director
- Jignesh Devubhai Suthar
- Chief Financial Officer
- Ummay Amen Mashraqi
- Compliance Officer, Company Secretary
- Chetan Mohan Joshi
- Managing Director, Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.